Summary
Akums Drugs and Pharmaceuticals is set to acquire Oriflame India's manufacturing business for fifty-six crore rupees, including two facilities and a warehouse. This strategic move aims to diversify Akums into high-growth colour cosmetics and is expected to conclude by August 31, 2026.